PBG BioPharma Inc. Announces the launch of a Phase 2/3 Clinical Trial on its Cannabinoid-based Drug Product ProZ-001 as an Adjunctive Therapy for Acute Bipolar Depression
PBG BioPharma Inc. Successfully Files Cannabinoid Master Drug File to Health Canada
PBG BioPharma achieves Food Safety System Certification (FSSC 22000)
Dr. Shan on OMNI TV - Nov 10, 2022
PBG BioPharma Inc. Announces Launch of GenBioChem® Line of Natural Health Products
CBG's Potential in Skincare
Study finds CBG potentially inhibits brain cancer growth
Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review
Dr. Shan on OMNI TV - Jun 15, 2022
CBD, CBG, CBN, CBC- What are they?
Oral THC:CBD extract reduces chemotherapy-induced nausea and vomiting
PBG BioPharma on Global News - April 29, 2022
CBD for Hair Regrowth
Effectiveness of Cannabis Oil in patients with Burning Mouth Syndrome
Medical Cannabis use for Tourette’s Syndrome
PBG BioPharma Inc. Receives Controlled Drug and Substances Dealer’s Licence
PBG BioPharma Inc. Receives Cannabis 2.0 Sales Amendment to Health Canada Licence
Clinical Outcomes of Medical Cannabis for Anxiety Disorder in UK
CBD Blocks SARS-CoV-2 Replication in Cells and Animal Models
A Randomized Trial of Medical Cannabis in Patients with Stage IV Cancers to Access Safety, Efficacy,
PARTNER WITH US
Got a project?
Let’s talk.
We’re a team of scientists who are excited about unique ideas and help cannabis companies realize their product vision.
